Interestingly, exogenous MG53 expression could dose-dependently repress the proliferation of cancer cells with relatively abundant cyclin D1 protein (Fig. 2f, g), but had very limited effects on cells with little cyclin D1 (Fig. 2f, h). This evidence concerns the gene TRIM72 and cancer.